BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 7331938)

  • 1. Single unit responses of substantia nigra and globus pallidus neurons to GABA agonist and antagonist drugs.
    Waszczak BL; Bergstrom DA; Walters JR
    Adv Biochem Psychopharmacol; 1981; 30():79-94. PubMed ID: 7331938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABAergic control of substantia nigra dopaminergic neurons.
    Tepper JM; Lee CR
    Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABAergic control of rat substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata.
    Celada P; Paladini CA; Tepper JM
    Neuroscience; 1999 Mar; 89(3):813-25. PubMed ID: 10199615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo.
    Paladini CA; Celada P; Tepper JM
    Neuroscience; 1999 Mar; 89(3):799-812. PubMed ID: 10199614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of GABA in the striatal output system: globus pallidus, nucleus entopeduncularis, substantia nigra and nucleus subthalamicus.
    Scheel-Krüger J; Magelund G; Olianas MC
    Adv Biochem Psychopharmacol; 1981; 30():165-86. PubMed ID: 7036675
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopamine D2, receptor-mediated modulation of the GABAergic inhibition of substantia nigra pars reticulata neurons.
    Martin LP; Waszczak BL
    Brain Res; 1996 Aug; 729(2):156-69. PubMed ID: 8876984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential role of GABAA and GABAB receptors in two distinct output stations of the rat striatum: studies on the substantia nigra pars reticulata and the globus pallidus.
    Ikeda H; Kotani A; Koshikawa N; Cools AR
    Neuroscience; 2010 Apr; 167(1):31-9. PubMed ID: 20132872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABAergic mechanisms in regulating the activity state of substantia nigra pars reticulata neurons.
    Windels F; Kiyatkin EA
    Neuroscience; 2006 Jul; 140(4):1289-99. PubMed ID: 16713116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pallidal control of substantia nigra dopaminergic neuron firing pattern and its relation to extracellular neostriatal dopamine levels.
    Lee CR; Abercrombie ED; Tepper JM
    Neuroscience; 2004; 129(2):481-9. PubMed ID: 15501605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic and spatial features of the inhibitory pallidal GABAergic synapses.
    Rav-Acha M; Sagiv N; Segev I; Bergman H; Yarom Y
    Neuroscience; 2005; 135(3):791-802. PubMed ID: 16154280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of GABA in the basal ganglia and limbic system for behaviour.
    Scheel-Krüger J; Magelund G; Olianas M
    Adv Biochem Psychopharmacol; 1981; 29():23-36. PubMed ID: 7020365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of GABA neurons in the expression of striatal motor functions.
    Di Chiara G; Porceddu ML; Imperato A; Morelli M
    Adv Biochem Psychopharmacol; 1981; 30():129-63. PubMed ID: 7036674
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of muscimol and picrotoxin on single unit activity of substantia nigra neurons.
    Waszczak BL; Eng N; Walters JR
    Brain Res; 1980 Apr; 188(1):185-97. PubMed ID: 7370752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of pallidal and nigral GABA mechanisms in the generation of tremulous jaw movements in rats.
    Finn M; Mayorga AJ; Conlan A; Salamone JD
    Neuroscience; 1997 Sep; 80(2):535-44. PubMed ID: 9284355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ; Marshall JF
    Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic and cholinergic stimulation of the ventrolateral striatum elicit rat jaw movements that are funnelled via distinct efferents.
    Adachi K; Hasegawa M; Fujita S; Sato M; Miwa Y; Ikeda H; Koshikawa N; Cools AR
    Eur J Pharmacol; 2002 May; 442(1-2):81-92. PubMed ID: 12020685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Excitatory effect of subthalamo-nigral and subthalamo-pallidal efferent pathways in the rat].
    Robledo P; Vezole I; Feger J
    C R Acad Sci III; 1988; 307(3):133-8. PubMed ID: 3144414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colocalization of excitatory and inhibitory neurotransmitter markers in striatal projection neurons in the rat.
    White LE; Hodges HD; Carnes KM; Price JL; Dubinsky JM
    J Comp Neurol; 1994 Jan; 339(3):328-40. PubMed ID: 7907614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral responses to injections of muscimol into the subthalamic nucleus: temporal changes after nigrostriatal lesions.
    Mehta A; Menalled L; Chesselet MF
    Neuroscience; 2005; 131(3):769-78. PubMed ID: 15730880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.
    Allen KL; Waldvogel HJ; Glass M; Faull RL
    J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.